NCT01585259View on ClinicalTrials.gov

Anfibatide Phase Ib-IIa Clinical Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

July 31, 2015

Conditions
Non-ST Segment Elevation Myocardial Infarction
Interventions
DRUG

Anfibatide

Snake venom

DRUG

Placebo

Saline

Trial Locations (1)

100000

Peking University First hospiatl, Beijing

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY